Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Melanie Paff, PhD
Vice President, Medicine Development Leader, HBV Program
Development, GSK, Collegeville, PA, USA
Poster(s):
049: Assessment of the Effect of HBV Viral Genotype on Bepirovirsen Efficacy Using a Population Pharmacokinetic/Pharmacodynamic Modeling Approach
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
